prostate cancer

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

The collaboration addresses delays in diagnosis and treatment by leveraging AI to help ensure patients with prostate and breast cancer are identified and treated more promptly.  

The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.

AI will be integrated to increase pathologists' efficiency.

The company pitches iQuest as a way for physicians to provide more precise cancer treatment and lessen the likelihood of negative side effects.

The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.

Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further.

Researchers zeroed in on the role of social media and spreading awareness around prostate cancer and the BRCA gene. 

Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries.

The interactive tool tackles prostate cancer symptoms, screening and treatment. Providers can use it during a clinical encounter to facilitate conversation.